France Infectious Diagnostics Market Outlook to 2024

Published : Nov-2017

No. of Pages : 162

order by fax Inquire before Buying request discount

Table of Contents

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6

2 Introduction 8
2.1 What Is This Report About? 8
2.2 Infectious Diagnostics Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 10

3 Infectious Diagnostics Market, France 15
3.1 Infectious Diagnostics Market, France, Revenue ($m), 2010-2017 15
3.2 Infectious Diagnostics Market, France, Revenue ($m), 2017-2024 18
3.2.1 Chlamydia trichomatis Diagnostic Test Kits Market, France, Revenue ($m), by Segment, 2010-2017 21
3.2.2 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Revenue ($m), by Segment, 2010-2017 23
3.2.3 Hepatitis Test Kits Market, France, Revenue ($m), by Segment, 2010-2017 25
3.2.4 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Revenue ($m), by Segment, 2010-2017 27
3.2.5 Infectious Diagnostics Multiple Parameter Test Kits Market, France, Revenue ($m), by Segment, 2010-2017 29
3.2.6 Infectious Diagnostics Rapid Tests & POC Market, France, Revenue ($m), by Segment, 2010-2017 31
3.2.7 Mycobacterium tuberculosis Diagnostic Tests Market, France, Revenue ($m), by Segment, 2010-2017 33
3.2.8 Polymerase Chain Reaction (PCR) Systems Market, France, Revenue ($m), by Segment, 2010-2017 35
3.2.9 Post Streptococcus pyogenes Diagnostic Tests Market, France, Revenue ($m), by Segment, 2010-2017 37
3.2.10 Retrovirus Tests Market, France, Revenue ($m), by Segment, 2010-2017 39
3.2.11 Treponema pallidum Diagnostic Tests Market, France, Revenue ($m), by Segment, 2010-2017 41
3.2.12 Chlamydia trichomatis Diagnostic Test Kits Market, France, Revenue ($m), by Segment, 2017-2024 43
3.2.13 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Revenue ($m), by Segment, 2017-2024 45
3.2.14 Hepatitis Test Kits Market, France, Revenue ($m), by Segment, 2017-2024 47
3.2.15 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Revenue ($m), by Segment, 2017-2024 49
3.2.16 Infectious Diagnostics Multiple Parameter Test Kits Market, France, Revenue ($m), by Segment, 2017-2024 51
3.2.17 Infectious Diagnostics Rapid Tests & POC Market, France, Revenue ($m), by Segment, 2017-2024 53
3.2.18 Mycobacterium tuberculosis Diagnostic Tests Market, France, Revenue ($m), by Segment, 2017-2024 55
3.2.19 Polymerase Chain Reaction (PCR) Systems Market, France, Revenue ($m), by Segment, 2017-2024 57
3.2.20 Post Streptococcus pyogenes Diagnostic Tests Market, France, Revenue ($m), by Segment, 2017-2024 59
3.2.21 Retrovirus Tests Market, France, Revenue ($m), by Segment, 2017-2024 61
3.2.22 Treponema pallidum Diagnostic Tests Market, France, Revenue ($m), by Segment, 2017-2024 63
3.3 Infectious Diagnostics Market, France, Volume (Units), 2010-2017 65
3.4 Infectious Diagnostics Market, France, Volume (Units), 2017-2024 67
3.4.1 Chlamydia trichomatis Diagnostic Test Kits Market, France, Volume (Units), by Segment, 2010-2017 70
3.4.2 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Volume (Units), by Segment, 2010-2017 72
3.4.3 Hepatitis Test Kits Market, France, Volume (Units), by Segment, 2010-2017 74
3.4.4 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Volume (Units), by Segment, 2010-2017 76
3.4.5 Infectious Diagnostics Multiple Parameter Test Kits Market, France, Volume (Units), by Segment, 2010-2017 78
3.4.6 Infectious Diagnostics Rapid Tests & POC Market, France, Volume (Units), by Segment, 2010-2017 80
3.4.7 Mycobacterium tuberculosis Diagnostic Tests Market, France, Volume (Units), by Segment, 2010-2017 82
3.4.8 Polymerase Chain Reaction (PCR) Systems Market, France, Volume (Units), by Segment, 2010-2017 84
3.4.9 Post Streptococcus pyogenes Diagnostic Tests Market, France, Volume (Units), by Segment, 2010-2017 86
3.4.10 Retrovirus Tests Market, France, Volume (Units), by Segment, 2010-2017 88
3.4.11 Treponema pallidum Diagnostic Tests Market, France, Volume (Units), by Segment, 2010-2017 90
3.4.12 Chlamydia trichomatis Diagnostic Test Kits Market, France, Volume (Units), by Segment, 2017-2024 92
3.4.13 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Volume (Units), by Segment, 2017-2024 94
3.4.14 Hepatitis Test Kits Market, France, Volume (Units), by Segment, 2017-2024 96
3.4.15 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Volume (Units), by Segment, 2017-2024 98
3.4.16 Infectious Diagnostics Multiple Parameter Test Kits Market, France, Volume (Units), by Segment, 2017-2024 100
3.4.17 Infectious Diagnostics Rapid Tests & POC Market, France, Volume (Units), by Segment, 2017-2024 102
3.4.18 Mycobacterium tuberculosis Diagnostic Tests Market, France, Volume (Units), by Segment, 2017-2024 104
3.4.19 Polymerase Chain Reaction (PCR) Systems Market, France, Volume (Units), by Segment, 2017-2024 106
3.4.20 Post Streptococcus pyogenes Diagnostic Tests Market, France, Volume (Units), by Segment, 2017-2024 108
3.4.21 Retrovirus Tests Market, France, Volume (Units), by Segment, 2017-2024 110
3.4.22 Treponema pallidum Diagnostic Tests Market, France, Volume (Units), by Segment, 2017-2024 112
3.5 Infectious Diagnostics Market, France, Average Price ($), 2010-2024 114
3.6 Infectious Diagnostics Market, France, Distribution Share by Revenue ($m), 2017 120
3.7 Infectious Diagnostics Market, France, Company Share by Revenue ($m), 2017 121

4 Overview of Key Companies in France, Infectious Diagnostics Market 123
4.1 Abbott Laboratories 123
4.1.1 Company Overview 123
4.2 F. Hoffmann-La Roche Ltd 123
4.2.1 Company Overview 123
4.3 Hologic Inc 123
4.3.1 Company Overview 123
4.4 Siemens Healthcare GmbH 124
4.4.1 Company Overview 124
4.5 Alere Inc 124
4.5.1 Company Overview 124
4.6 Qiagen NV 124
4.6.1 Company Overview 124
4.7 Beckman Coulter Inc 124
4.7.1 Company Overview 124
4.8 Cepheid 125
4.8.1 Company Overview 125
4.9 Bio-Rad Laboratories Inc 125
4.9.1 Company Overview 125
4.10 Thermo Fisher Scientific Inc 125
4.10.1 Company Overview 125

5 Infectious Diagnostics Market Pipeline Products 126

6 Financial Deals Landscape 129
6.1 Equity Offerings 129
6.1.1 TheraDiag to Raise up to USD4.4 Million in Private Placement of Shares 129
6.1.2 Diaxonhit to Raise USD9.5 Million in public offering of shares 130
6.2 Partnerships 131
6.2.1 iBio Enters into Agreement with TheoremDx 131
6.2.2 SpeeDx Enters into Distribution Agreement with Cepheid 132
6.2.3 Stellar Biotech Terminates Licensing Agreement with University of Guelph 133
6.2.4 Laboratoire Cerba Enters into Licensing Agreement with PathoQuest for iDTECT Blood test 134
6.3 Private Equity 135
6.3.1 PAI Partners to Acquire ELITech from Ergon Capital Partners 135

7 Recent Developments 136
7.1 Corporate Communications 136
7.1.1 Mar 01, 2017: Appointment of Dominique Costantini and Dominique Takizawa to Theradiag's Board of Directors 136
7.1.2 Dec 01, 2016: Unum Therapeutics to Present on its Antibody-Coupled T-Cell Receptor (ACTR) Platform at the Upcoming 58th American Society of Hematology Annual Meeting 136
7.1.3 Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux 138
7.2 Financial Announcements 138
7.2.1 Oct 26, 2017: Theradiag: Revenues at the end of September 30, 2017 138
7.2.2 Sep 19, 2017: Theradiag: Results and activity for the first half of 2017 Continued improvement in results 138
7.2.3 Aug 30, 2017: bioMerieux - First-Half 2017 Results 140
7.2.4 Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9% 142
7.2.5 Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review 143
7.2.6 Apr 27, 2017: THERADIAG Announces First-quarter 2017 Revenues 145
7.2.7 Apr 27, 2017: Theradiag: First-Quarter 2017 Revenues 145
7.2.8 Apr 20, 2017: bioMerieux - First-Quarter 2017 Business Review 145
7.2.9 Mar 01, 2017: THERADIAG: Full-year 2016 results 147
7.2.10 Mar 01, 2017: bioMerieux - 2016 Financial Results 149
7.2.11 Jan 19, 2017: bioMerieux - Fourth-Quarter 2016 Business Review 151
7.3 Other Significant Developments 153
7.3.1 Oct 18, 2017: bioMerieux - Business review for the nine months ended September 30, 2017 153

8 Appendix 156
8.1 Research Methodology 157
8.1.1 Coverage 157
8.1.2 Secondary Research 157
8.1.3 Primary Research 158
8.1.4 Market Modeling and Forecasting 159
8.1.5 Company Share Analysis 160
8.1.6 Distribution Share Analysis 161
8.1.7 Benchmarking 161
8.2 GlobalData Consulting 161
8.3 Contact Us 162
8.4 Disclaimer 162

List of Tables

Table 1: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 16
Table 2: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 19
Table 3: Chlamydia trichomatis Diagnostic Test Kits Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 22
Table 4: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 24
Table 5: Hepatitis Test Kits Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 26
Table 6: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 28
Table 7: Infectious Diagnostics Multiple Parameter Test Kits Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 30
Table 8: Infectious Diagnostics Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 32
Table 9: Mycobacterium tuberculosis Diagnostic Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 34
Table 10: Polymerase Chain Reaction (PCR) Systems Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 36
Table 11: Post Streptococcus pyogenes Diagnostic Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 38
Table 12: Retrovirus Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 40
Table 13: Treponema pallidum Diagnostic Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 42
Table 14: Chlamydia trichomatis Diagnostic Test Kits Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 44
Table 15: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 46
Table 16: Hepatitis Test Kits Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 48
Table 17: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 50
Table 18: Infectious Diagnostics Multiple Parameter Test Kits Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 52
Table 19: Infectious Diagnostics Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 54
Table 20: Mycobacterium tuberculosis Diagnostic Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 56
Table 21: Polymerase Chain Reaction (PCR) Systems Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 58
Table 22: Post Streptococcus pyogenes Diagnostic Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 60
Table 23: Retrovirus Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 62
Table 24: Treponema pallidum Diagnostic Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 64
Table 25: Infectious Diagnostics Market, France, Volume (Units), Historic, 2010-2017 66
Table 26: Infectious Diagnostics Market, France, Volume (Units), Forecast, 2017-2024 68
Table 27: Chlamydia trichomatis Diagnostic Test Kits Market, France, Volume (Units), Historic, 2010-2017 71
Table 28: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Volume (Units), Historic, 2010-2017 73
Table 29: Hepatitis Test Kits Market, France, Volume (Units), Historic, 2010-2017 75
Table 30: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Volume (Units), Historic, 2010-2017 77
Table 31: Infectious Diagnostics Multiple Parameter Test Kits Market, France, Volume (Units), Historic, 2010-2017 79
Table 32: Infectious Diagnostics Rapid Tests & POC Market, France, Volume (Units), Historic, 2010-2017 81
Table 33: Mycobacterium tuberculosis Diagnostic Tests Market, France, Volume (Units), Historic, 2010-2017 83
Table 34: Polymerase Chain Reaction (PCR) Systems Market, France, Volume (Units), Historic, 2010-2017 85
Table 35: Post Streptococcus pyogenes Diagnostic Tests Market, France, Volume (Units), Historic, 2010-2017 87
Table 36: Retrovirus Tests Market, France, Volume (Units), Historic, 2010-2017 89
Table 37: Treponema pallidum Diagnostic Tests Market, France, Volume (Units), Historic, 2010-2017 91
Table 38: Chlamydia trichomatis Diagnostic Test Kits Market, France, Volume (Units), Forecast, 2017-2024 93
Table 39: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Volume (Units), Forecast, 2017-2024 95
Table 40: Hepatitis Test Kits Market, France, Volume (Units), Forecast, 2017-2024 97
Table 41: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Volume (Units), Forecast, 2017-2024 99
Table 42: Infectious Diagnostics Multiple Parameter Test Kits Market, France, Volume (Units), Forecast, 2017-2024 101
Table 43: Infectious Diagnostics Rapid Tests & POC Market, France, Volume (Units), Forecast, 2017-2024 103
Table 44: Mycobacterium tuberculosis Diagnostic Tests Market, France, Volume (Units), Forecast, 2017-2024 105
Table 45: Polymerase Chain Reaction (PCR) Systems Market, France, Volume (Units), Forecast, 2017-2024 107
Table 46: Post Streptococcus pyogenes Diagnostic Tests Market, France, Volume (Units), Forecast, 2017-2024 109
Table 47: Retrovirus Tests Market, France, Volume (Units), Forecast, 2017-2024 111
Table 48: Treponema pallidum Diagnostic Tests Market, France, Volume (Units), Forecast, 2017-2024 113
Table 49: Infectious Diagnostics Market, France, Average Price ($) Historic, 2010-2017 114
Table 50: Infectious Diagnostics Market, France, Average Price ($), Forecast, 2017-2024 117
Table 51: Infectious Diagnostics Market, France, Distribution Share by Revenue ($m), USD Constant, 2017 120
Table 52: Infectious Diagnostics Market, France, Company Share by Revenue ($m), USD Constant, 2017 122
Table 53: Infectious Diagnostics Market Pipeline Products 126
Table 54: TheraDiag to Raise up to USD4.4 Million in Private Placement of Shares 129
Table 55: Diaxonhit to Raise USD9.5 Million in public offering of shares 130
Table 56: iBio Enters into Agreement with TheoremDx 131
Table 57: SpeeDx Enters into Distribution Agreement with Cepheid 132
Table 58: Stellar Biotech Terminates Licensing Agreement with University of Guelph 133
Table 59: Laboratoire Cerba Enters into Licensing Agreement with PathoQuest for iDTECT Blood test 134
Table 60: PAI Partners to Acquire ELITech from Ergon Capital Partners 135
Table 61: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 159

List of Figures

Figure 1: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 15
Figure 2: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 18
Figure 3: Chlamydia trichomatis Diagnostic Test Kits Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 21
Figure 4: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 23
Figure 5: Hepatitis Test Kits Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 25
Figure 6: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 27
Figure 7: Infectious Diagnostics Multiple Parameter Test Kits Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 29
Figure 8: Infectious Diagnostics Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 31
Figure 9: Mycobacterium tuberculosis Diagnostic Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 33
Figure 10: Polymerase Chain Reaction (PCR) Systems Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 35
Figure 11: Post Streptococcus pyogenes Diagnostic Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 37
Figure 12: Retrovirus Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 39
Figure 13: Treponema pallidum Diagnostic Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 41
Figure 14: Chlamydia trichomatis Diagnostic Test Kits Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 43
Figure 15: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 45
Figure 16: Hepatitis Test Kits Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 47
Figure 17: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 49
Figure 18: Infectious Diagnostics Multiple Parameter Test Kits Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 51
Figure 19: Infectious Diagnostics Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 53
Figure 20: Mycobacterium tuberculosis Diagnostic Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 55
Figure 21: Polymerase Chain Reaction (PCR) Systems Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 57
Figure 22: Post Streptococcus pyogenes Diagnostic Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 59
Figure 23: Retrovirus Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 61
Figure 24: Treponema pallidum Diagnostic Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 63
Figure 25: Infectious Diagnostics Market, France, Volume (Units), Historic, 2010-2017 65
Figure 26: Infectious Diagnostics Market, France, Volume (Units), Forecast, 2017-2024 67
Figure 27: Chlamydia trichomatis Diagnostic Test Kits Market, France, Volume (Units), Historic, 2010-2017 70
Figure 28: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Volume (Units), Historic, 2010-2017 72
Figure 29: Hepatitis Test Kits Market, France, Volume (Units), Historic, 2010-2017 74
Figure 30: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Volume (Units), Historic, 2010-2017 76
Figure 31: Infectious Diagnostics Multiple Parameter Test Kits Market, France, Volume (Units), Historic, 2010-2017 78
Figure 32: Infectious Diagnostics Rapid Tests & POC Market, France, Volume (Units), Historic, 2010-2017 80
Figure 33: Mycobacterium tuberculosis Diagnostic Tests Market, France, Volume (Units), Historic, 2010-2017 82
Figure 34: Polymerase Chain Reaction (PCR) Systems Market, France, Volume (Units), Historic, 2010-2017 84
Figure 35: Post Streptococcus pyogenes Diagnostic Tests Market, France, Volume (Units), Historic, 2010-2017 86
Figure 36: Retrovirus Tests Market, France, Volume (Units), Historic, 2010-2017 88
Figure 37: Treponema pallidum Diagnostic Tests Market, France, Volume (Units), Historic, 2010-2017 90
Figure 38: Chlamydia trichomatis Diagnostic Test Kits Market, France, Volume (Units), Forecast, 2017-2024 92
Figure 39: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Volume (Units), Forecast, 2017-2024 94
Figure 40: Hepatitis Test Kits Market, France, Volume (Units), Forecast, 2017-2024 96
Figure 41: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Volume (Units), Forecast, 2017-2024 98
Figure 42: Infectious Diagnostics Multiple Parameter Test Kits Market, France, Volume (Units), Forecast, 2017-2024 100
Figure 43: Infectious Diagnostics Rapid Tests & POC Market, France, Volume (Units), Forecast, 2017-2024 102
Figure 44: Mycobacterium tuberculosis Diagnostic Tests Market, France, Volume (Units), Forecast, 2017-2024 104
Figure 45: Polymerase Chain Reaction (PCR) Systems Market, France, Volume (Units), Forecast, 2017-2024 106
Figure 46: Post Streptococcus pyogenes Diagnostic Tests Market, France, Volume (Units), Forecast, 2017-2024 108
Figure 47: Retrovirus Tests Market, France, Volume (Units), Forecast, 2017-2024 110
Figure 48: Treponema pallidum Diagnostic Tests Market, France, Volume (Units), Forecast, 2017-2024 112
Figure 49: Infectious Diagnostics Market, France, Company Share (%) 2017 121

Filed in: Diagnostics

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) – Global Forecast to 2027 “Increasing prevalence of infectious diseases and the rising funding for R&D are driving the overall growth of the infectious disease diagnostics market” The global infectious disease diagnostics market size is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR. Market is driven by factors such as indication of infectious diseases, growing trend in POC testing and rising technological advancements. However, an unfavorable reimbursement scenario is expected to limit market growth to a certain extent in the forecasted years. “The reagents, kits, and consumables accounted for the largest market share in the infectious disease diagnostics market, by product & service, during the forecast period” The infectious disease diagnostics......	$4950
In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) – Global Forecast to 2027 “The global in vitro toxicology testing market is projected to grow at a CAGR of 10.8%.” The in vitro toxicology testing market is expected to reach USD 18.6 billion by 2027 from an estimated USD 11.2 billion in 2022, at a CAGR of 10.8%.Factors such as, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the factors to drive the market “The ADME segment is expected to account for the largest market share in 2021.” Based on toxicity endpoints and tests undertaken across all industries, the in vitro toxicity testing market is segmented into genotoxicity; cytotoxicity; ADME; skin irritation, corrosion, & sensitization; ocular toxicity; organ toxicity; phototoxicity; dermal toxicity; and other endp......	$4950
Molecular Diagnostics Market by Product & Service (Reagents, Kits, Instruments), Test Type (Lab, PoC), Technology (PCR, INAAT, NGS, ISH), Application (Infectious, Oncology, Genetic Testing), End User (Diagnostic Labs, Hospitals) – Global Forecast to 2027 “Rising funding for R&D in molecular diagnostics and increasing prevalence of infectious diseases and cancer are driving the overall growth of the molecular diagnostics market” The global molecular diagnostics market is projected to reach USD 30.2 billion by 2027 from USD 23.2 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as the increasing use of PoC diagnostic tests, the rising funding for R&D in molecular diagnostics, the increasing prevalence of infectious diseases and cancer. On the other hand, an unfavorable reimbursement scenario and the high cost of instruments may restrain the growth of this market to a certain extent. “The DNA sequencing & NGS segment accounted for the highest growth rate in the molec......	$4950
Laboratory Proficiency Testing Market by Industry (Clinical Chemistry, Hematology), Food & Animal Feed (Fish, Vegetable), Commercial Beverage (Alcohol), Microbiology, Water, Environmental) by Technology (PCR) – Global Forecast to 2026 “The rising an essential precondition for operational excellence and accreditation in several industries is expected to drive the overall growth of the laboratory proficiency testing market.” The global laboratory proficiency testing market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.4%. With proficiency testing being a mandatory procedure to be undertaken by laboratories functioning in different industries which are under regulation by organizations such as the CLIA, APLAC, and CLSI, the market for proficiency testing is expected to witness significant growth during the forecast period. PT forms an essential precondition for operational excellence and accreditation in several industries. This is one of the major factors driving the gro......	$4950
Liquid Handling System Market by Product (Pipettes, Consumables, Microplate Reagent Dispensers, Liquid Handling Workstations, Burettes, Microplate Washers, Software), Type, Application, End User and Region – Global Forecast to 2026 “The Liquid Handling System market is projected to grow at CAGR of 5.1% from 2021 to 2026” The global liquid handling systems market is expected to reach USD 5.1 billion by 2026 from USD 4.0 billion in 2021, at a CAGR of 5.1% during the forecast period. The growth of this market is majorly driven by industrial growth in the pharma-biotech sector, rising R&D expenditure by biopharma companies, and growing life science research, supported by a favorable funding scenario. However, the slow adoption of automation among small and medium-sized laboratories may restrain the market growth. “Pipettes in the product segment to witness the highest growth during the forecast period.” Based on the products, the global liquid handling system market is segmented into Pipettes, Consum......	$4950
In-Vitro Diagnostics/IVD Market by Product and Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) – Global Forecast to 2026 The global IVD market is projected to reach USD 113.1 billion by 2026 from USD 98.2 billion in 2021, at a CAGR of 2.9% during the forecast period. The growth of the IVD market is mainly driven by the rising geriatric population and the subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated and POC instruments in developed regions, growing awareness regarding diseases diagnosis in developing regions, and growing R&D investments by industry players to launch new IVD products. Also, the development of disease-specific markers and tests is expected to offer potential growth opportunities to market players in the coming years. However, the unfavorable reimbursement scenario is expected to restrain the growth of this market during the f......	$4950
Point of Care & Rapid Diagnostics Market by Product (Glucose, Infectious Disease(HIV, Hepatitis C), Pregnancy Test), Platform (Microfluidics, Dipsticks), Mode of Purchase (OTC, Prescription), End User (Pharmacy, Hospital, Home) – Global Forecast to 2027 “Dearth of skilled laboratory technicians” The global point of care diagnostics market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027. Point-of-care testing (POCT) includes screening or diagnostic tests performed outside traditional laboratories. These tests are designed to be used at or near the site where the patient is located (such as at home, in an ambulance, at a physician’s office, and other locations). POCT allows rapid and reliable diagnostic testing through which outcomes can be obtained instantly, helping physicians/patients to make decisions related to care remotely and as soon as possible. Market growth is mainly driven by the high prevalence of infectious diseases, supportive government p......	$4950
Organ Preservation Market by Solution (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) – Global Forecast to 2026 The organ preservation market is expected to grow at a CAGR of 6.6% in the forecast period. The global organ preservation market is projected to reach USD 317 million by 2026 from USD 270 million in 2021, at a CAGR of 6.6%.Growth in this market is majorly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations. However, concerns related to the high cost of organ transplantations and religious concerns in specific geographies are expected to limit the growth of this market to a certain extent. “The University of Wisconsin (UW) holds the largest market share in the solution market.” Based on the Solution, the segment is divided ......	$4950
Medical Refrigerators Market by Type, End Use (Blood Banks, Pharmaceutical Companies, Hospital & Pharmacies, Research Institutes, Medical Laboratories, Diagnostic Centre), & Region(North America, Europe, APAC, MEA, South America) – Global Forecast to 2026 The medical refrigerators market was valued at USD 3.5 Billion in 2020 and is projected to reach USD 4.9 Billion by 2026, at a CAGR of 6.0% during the forecast period. The medical refrigerators market is on course for intense growth across different end use industries such as blood banks, pharmaceutical companies, hospitals, & pharmacies, research institutes, medical laboratories, and diagnostic centers. “The ultra-low temperature freezers segment, by value, is projected to grow at the highest CAGR during the forecast period” By product type, ultra-low temperature freezers segment is expected to grow at the highest CAGR during 2021 to 2026, by value. Ultra-low temperature freezers (ULT freezers) are used for the storage of drugs, enzymes, chemicals, bacteria, viruses, cell pr......	$4950
Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) – Global Forecast to 2026 “Increasing prevalence of infectious diseases and cancer and the rising funding for R&D are driving the overall growth of the point-of-care molecular diagnostics market” The global point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2% during the forecast period. Market growth is driven by factors such as the increasing prevalence of infectious diseases and cancer, rising focus on decentralized diagnostics and increasing R&D funding, increasing awareness on the early detection of infectious diseases, and the increasing use of POC diagnostic tests. On the other hand, stringent and time-consuming regulatory policies that significantly increase the product launch cycle may challenge market gr......	$4950

France Infectious Diagnostics Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) – Global Forecast to 2027

In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) – Global Forecast to 2027

Molecular Diagnostics Market by Product & Service (Reagents, Kits, Instruments), Test Type (Lab, PoC), Technology (PCR, INAAT, NGS, ISH), Application (Infectious, Oncology, Genetic Testing), End User (Diagnostic Labs, Hospitals) – Global Forecast to 2027

Laboratory Proficiency Testing Market by Industry (Clinical Chemistry, Hematology), Food & Animal Feed (Fish, Vegetable), Commercial Beverage (Alcohol), Microbiology, Water, Environmental) by Technology (PCR) – Global Forecast to 2026

Liquid Handling System Market by Product (Pipettes, Consumables, Microplate Reagent Dispensers, Liquid Handling Workstations, Burettes, Microplate Washers, Software), Type, Application, End User and Region – Global Forecast to 2026

In-Vitro Diagnostics/IVD Market by Product and Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) – Global Forecast to 2026

Point of Care & Rapid Diagnostics Market by Product (Glucose, Infectious Disease(HIV, Hepatitis C), Pregnancy Test), Platform (Microfluidics, Dipsticks), Mode of Purchase (OTC, Prescription), End User (Pharmacy, Hospital, Home) – Global Forecast to 2027

Organ Preservation Market by Solution (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) – Global Forecast to 2026

Medical Refrigerators Market by Type, End Use (Blood Banks, Pharmaceutical Companies, Hospital & Pharmacies, Research Institutes, Medical Laboratories, Diagnostic Centre), & Region(North America, Europe, APAC, MEA, South America) – Global Forecast to 2026

Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) – Global Forecast to 2026